Open AccessColorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis
Author(s) -
Alonso Vera,
Bridget Gunson,
Val Ussatoff,
Peter Nightingale,
Daniel Candinas,
Stephen Radley,
A. David Mayer,
John Buckels,
Paul McMaster,
James Neuberger,
Darius F. Mirza
Publication year - 2003
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000058744.34965.38
Subject(s) - medicine , primary sclerosing cholangitis , gastroenterology , inflammatory bowel disease , colorectal cancer , ulcerative colitis , liver transplantation , colectomy , immunosuppression , dysplasia , transplantation , cancer , disease
Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) may have an increased risk of developing colorectal cancer (CRC) after liver transplantation (LT). We evaluated our patients with PSC after LT to identify risk factors for CRC and its impact on survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom